NASDAQ: FORAForian Inc Stock
$2.52-0.14 (-5.26%)
Updated Apr 18, 2024
FORA Price
$2.52
Fair Value Price
N/A
Market Cap
$78.45M
52 Week Low
$1.85
52 Week High
$4.15
P/E
7.41x
P/B
3x
P/S
4.57x
PEG
N/A
Dividend Yield
N/A
Revenue
$20.48M
Earnings
$11.11M
Gross Margin
73.3%
Operating Margin
58.72%
Profit Margin
54.2%
Debt to Equity
1.25
Operating Cash Flow
$729k
Beta
0.66
Next Earnings
May 10, 2024
Ex-Dividend
N/A
Next Dividend
N/A
FORA Overview
Forian Inc. provides software solutions, proprietary data-driven insights, and predictive analytics to the healthcare, cannabis, and government sectors. The company's products include BioTrack, Cannalytics, BioTrack State Traceability & Enforcement Monitoring System, and STEMS. The company also offers security monitoring and web marketing services. The company is headquartered in Newtown, PA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FORA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FORA is good value based on its earnings relative to its share price (7.41x), compared to the US market average (41.33x)
P/E vs Market Valuation
FORA is good value based on its earnings relative to its share price (7.41x), compared to the US Health Information Services industry average (74.25x)
P/E vs Industry Valuation
FORA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more FORA due diligence checks available for Premium users.
Be the first to know about important FORA news, forecast changes, insider trades & much more!
FORA News
Valuation
FORA fair value
Fair Value of FORA stock based on Discounted Cash Flow (DCF)
Price
$2.52
Fair Value
$2.81
Undervalued by
10.19%
FORA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
7.41x
Industry
74.25x
Market
41.33x
FORA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FORA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
FORA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3x
Industry
3.36x
FORA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FORA's financial health
Profit margin
Revenue
$5.4M
Net Income
$1.4M
Profit Margin
25.9%
FORA's Earnings (EBIT) of $12.03M... subscribe to Premium to read more.
Interest Coverage Financials
FORA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$58.9M
Liabilities
$32.7M
Debt to equity
1.25
FORA's short-term assets ($57.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FORA's short-term assets ($57.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FORA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
FORA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$599.5k
Investing
$4.8M
Financing
-$3.5M
FORA's operating cash flow ($728.82k)... subscribe to Premium to read more.
Debt Coverage Financials
FORA vs Health Information Service Stocks
Forian Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.